Do assisted reproductive technologies implicate epigenetic risks? by Sayeras Haag, Rosa Cristina & Universitat Autònoma de Barcelona. Facultat de Biociències
Do Assisted Reproductive Technologies Implicate  Epigenetic Risks? 
 
Rosa Cristina Sayeras Haag, Biomedical Sciences, UAB 
 
Mentor:  Dra. Francesca Vidal,  Department of Cell Biology, Phisiology and Immunology, UAB 
Introduction 
Recent estimations suggest that 1 in 10 people of reproductive age are infertile. There is a high percentage of couples requesting the use of Assisted Reproductive Technology (ART).   Although some risks due to the use of this technology have been described, ART are considered safe. However, there is 
some controversy about ART contribution to increased epigenetic risk in offspring.  After commenting the genetic imprinting cycle and their relation with ART, epigenetic risks due to this technology will be revised. 
             
Genetic imprinting 
Imprinted genes has either a paternal or maternal expression (figure 1). Errors in the 
imprinting marks can be responsible for human diseases such as Angelman Syndrome (AS) 
or Beckwith-Widemann Syndrome (BWS).  
 
Genomic imprinting requires sex-specific marks in the genome which imply a resetting of 
these marks in every generation. The imprinting cycle (figure 2) consists in three phases: 
ART and imprinting  
The use of ART necessarily involves the acquisition and sometimes manipulation of gametes, 
zygotes or embryos during the time when imprinting takes place. The most discussed 
procedures used in ART as possible inductors of imprinting errors are: 
 
 
ART and human disease  
Since 2002 several studies have been published describing an increased risk of AS and BWS 
after the use of ART, and especially after the use of IVF and ICSI.  
 
 
Angelman Syndrome 
Neurodevelopmental disorder   
(1 in 16.000 births) 
 
In a general population 5% of AS 
cases are due to imprinting errors 
 
The 35’3% of ART-associated AS 
have aberrant imprinting.  
 
Beckwith-Widemann Syndrome 
Overgrowth disorder with  
(1 in 13.700 births) 
 
In a general population 50-60% of BWS 
cases are due to imprinting errors 
 
The 58’7% of ART-associated BWS  
have aberrant imprinting 
Glossary 
 
ART: all treatments or procedures used for the purpose of achieving a pregnancy. ART 
includes, but it is not limited to, handling of human gametes or of embryos, in vitro 
fertilization, embryo transfer and gametes or embryo cryopreservation. ART does not 
include assisted insemination. 
 
Infertility: a disease of the reproductive system defined by the failure to achieve a 
clinical pregnancy after 12 months or more of regular unprotected sexual intercourse. 
 
Epigenetics: gene expression regulation based on changes in the chromatin structure 
that is not dependent on the DNA sequence and is inheritable.  
 
Imprinted genes: genes that have a monoallelic expression due to an epigenetic 
regulation. 
Conclusions  
Considering the overlap between the majority of epigenetic reprogramming events during the gametogenesis or the embryonic development and the timing of ART, it is possible that suboptimal conditions 
in ART may induce imprinting errors.  But, is there a real risk? 
Yes, there are risks 
There is an increased number of ART-associated imprinting 
disorders caused by aberrant imprinting 
No, there are no risks 
The recent cohort studies have failed to confirm the association 
between ART and imprinting disorders 
MORE 
STUDIES ARE 
NEEDED 
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Figure 1. Non-imprinted genes are expressed from either both 
alleles (gene A) or none of them (gene B). Imprinted genes have 
a monoallelic expression, therefore they allow only the paternal 
allele (gene C) or the maternal allele (gene D) expression.  
 
Adapted from: Eroglu et al. Semin Reprod Med. 2012;30:92-104   
 
Figure 2. Methylation dynamics during germ cells development, fertilization and early embryo development. Methylation dynamics of paternal and maternal imprinted genes are shown by the dark blue and dark red lines 
respectively. Light blue and light red show the methylation dynamics of  paternal and maternal non-imprinted genes respectively.  The phases during development when ART procedures may induce imprinting errors are: SOPS 
=suboptimal sperm, SO = superovulation, IVM =in vitro maturation of oocytes, IVF = in vitro fertilization, ICSI =intracytoplasmic sperm injection, EC = embryo culture. 
   
Adapted from: Lucifero et al. Hum Reprod Update. 2004;10:3-18   
 
Non imprinted Genes 
        Expressed Gene        Non-Expressed Gene 
Imprinted Genes 
    Paternal Expressed Gene    Maternal Expressed Gene 
   C                                               D 
   C                                               D 
   A                                               B 
   A                                               B 
Superovulation: premature release of oocytes 
In vitro maturation of oocytes: abnormal environment for the gametes maturation  
The use of suboptimal sperm: immature imprinting marks 
In vitro fertilization: abnormal environment   
ICSI: stress due to the procedure 
Embryo culture: abnormal environment when general demethylation occurs 
Erasure: takes place in the primordial germ cells (PGCs).  
Establishment: takes place during the germ cells development. Imprinting marks are 
acquired earlier in the development in male gametes than in females. 
Maintenance: during the early embryo development there is a general 
demethylation of the genome that does not affect imprinted genes.  
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